NEKTAR THERAPEUTICS — Director's Dealing 2019

Sep 28, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2019-09-25

Reporting Person: CHESS ROBERT (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-09-25	Common Stock	A	6500	$0.00	Acquired	280973	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-25	Stock Option	$18.80	A	13000	Acquired	2027-09-24	Common Stock (13000)	Direct

Footnotes

F1: This stock award was acquired pursuant to a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.

F2: This restricted stock unit award vests in full, one year following September 25, 2019.

F3: This stock option vests in equal monthly installments over the one-year period beginning on September 30, 2019.